COVID-19 Impact on Global Tuberculosis Diagnostics and Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Tuberculosis Diagnostics and Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Skin Testing
  • 1.4.3 Laboratory Testing
• 1.5 Market by Application
  • 1.5.1 Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Tuberculosis Diagnostics and Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Tuberculosis Diagnostics and Treatment Industry
    • 1.6.1.1 Tuberculosis Diagnostics and Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Tuberculosis Diagnostics and Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Tuberculosis Diagnostics and Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Tuberculosis Diagnostics and Treatment Market Perspective (2015-2026)
• 2.2 Tuberculosis Diagnostics and Treatment Growth Trends by Regions
  • 2.2.1 Tuberculosis Diagnostics and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Tuberculosis Diagnostics and Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Tuberculosis Diagnostics and Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Tuberculosis Diagnostics and Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Tuberculosis Diagnostics and Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Tuberculosis Diagnostics and Treatment Players by Market Size
  • 3.1.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio
  • 3.2.1 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics and Treatment Revenue in 2019
• 3.3 Tuberculosis Diagnostics and Treatment Key Players Head office and Area Served
• 3.4 Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
• 3.5 Date of Enter into Tuberculosis Diagnostics and Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2021-2026)

5 Tuberculosis Diagnostics and Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)
• 5.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
• 6.2 Tuberculosis Diagnostics and Treatment Key Players in North America (2019-2020)
• 6.3 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
• 6.4 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
• 7.2 Tuberculosis Diagnostics and Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
• 7.4 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
• 8.2 Tuberculosis Diagnostics and Treatment Key Players in China (2019-2020)
• 8.3 China Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
• 8.4 China Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
• 9.2 Tuberculosis Diagnostics and Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
• 9.4 Japan Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
• 10.2 Tuberculosis Diagnostics and Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
• 11.2 Tuberculosis Diagnostics and Treatment Key Players in India (2019-2020)
• 11.3 India Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
• 11.4 India Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
• 12.2 Tuberculosis Diagnostics and Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Cepheid Inc
  • 13.1.1 Cepheid Inc Company Details
  • 13.1.2 Cepheid Inc Business Overview and Its Total Revenue
  • 13.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Introduction
  • 13.1.4 Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020))
  • 13.1.5 Cepheid Inc Recent Development
• 13.2 Becton Dickinson
  • 13.2.1 Becton Dickinson Company Details
  • 13.2.2 Becton Dickinson Business Overview and Its Total Revenue
  • 13.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Introduction
  • 13.2.4 Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 13.2.5 Becton Dickinson Recent Development
• 13.3 Hain LifeSciences
  • 13.3.1 Hain LifeSciences Company Details
  • 13.3.2 Hain LifeSciences Business Overview and Its Total Revenue
  • 13.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Introduction
  • 13.3.4 Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 13.3.5 Hain LifeSciences Recent Development
• 13.4 Abbott Laboratories
  • 13.4.1 Abbott Laboratories Company Details
  • 13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
  • 13.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Introduction
  • 13.4.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 13.4.5 Abbott Laboratories Recent Development
• 13.5 Alere, Inc
  • 13.5.1 Alere, Inc Company Details
  • 13.5.2 Alere, Inc Business Overview and Its Total Revenue
  • 13.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Introduction
  • 13.5.4 Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 13.5.5 Alere, Inc Recent Development
• 13.6 Roche AG
  • 13.6.1 Roche AG Company Details
  • 13.6.2 Roche AG Business Overview and Its Total Revenue
  • 13.6.3 Roche AG Tuberculosis Diagnostics and Treatment Introduction
  • 13.6.4 Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 13.6.5 Roche AG Recent Development
• 13.7 Hologic Corporation
  • 13.7.1 Hologic Corporation Company Details
  • 13.7.2 Hologic Corporation Business Overview and Its Total Revenue
  • 13.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Introduction
  • 13.7.4 Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 13.7.5 Hologic Corporation Recent Development
• 13.8 bioMerieux
  • 13.8.1 bioMerieux Company Details
  • 13.8.2 bioMerieux Business Overview and Its Total Revenue
  • 13.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Introduction
  • 13.8.4 bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 13.8.5 bioMerieux Recent Development
• 13.9 Sanofi
  • 13.9.1 Sanofi Company Details
  • 13.9.2 Sanofi Business Overview and Its Total Revenue
  • 13.9.3 Sanofi Tuberculosis Diagnostics and Treatment Introduction
  • 13.9.4 Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 13.9.5 Sanofi Recent Development
• 13.10 QIAGEN
  • 13.10.1 QIAGEN Company Details
  • 13.10.2 QIAGEN Business Overview and Its Total Revenue
  • 13.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Introduction
  • 13.10.4 QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 13.10.5 QIAGEN Recent Development
• 13.11 Akonni Biosystems, Inc.
  • 10.11.1 Akonni Biosystems, Inc. Company Details
  • 10.11.2 Akonni Biosystems, Inc. Business Overview and Its Total Revenue
  • 10.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Introduction
  • 10.11.4 Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 10.11.5 Akonni Biosystems, Inc. Recent Development
• 13.12 Epistem Holdings Plc
  • 10.12.1 Epistem Holdings Plc Company Details
  • 10.12.2 Epistem Holdings Plc Business Overview and Its Total Revenue
  • 10.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Introduction
  • 10.12.4 Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 10.12.5 Epistem Holdings Plc Recent Development
• 13.13 Gen-Probe Inc.
  • 10.13.1 Gen-Probe Inc. Company Details
  • 10.13.2 Gen-Probe Inc. Business Overview and Its Total Revenue
  • 10.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Introduction
  • 10.13.4 Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 10.13.5 Gen-Probe Inc. Recent Development
• 13.14 EIKEN Chemical
  • 10.14.1 EIKEN Chemical Company Details
  • 10.14.2 EIKEN Chemical Business Overview and Its Total Revenue
  • 10.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Introduction
  • 10.14.4 EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 10.14.5 EIKEN Chemical Recent Development
• 13.15 Thermo Fisher Scientific, Inc
  • 10.15.1 Thermo Fisher Scientific, Inc Company Details
  • 10.15.2 Thermo Fisher Scientific, Inc Business Overview and Its Total Revenue
  • 10.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Introduction
  • 10.15.4 Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
  • 10.15.5 Thermo Fisher Scientific, Inc Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer